686 related articles for article (PubMed ID: 17002629)
1. Surveillance of risk profiles among new and repeat blood donors with transfusion-transmissible infections from 1995 through 2003 in the Netherlands.
Van der Bij AK; Coutinho RA; Van der Poel CL
Transfusion; 2006 Oct; 46(10):1729-36. PubMed ID: 17002629
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of transfusion-associated viral infections and syphilis among blood donors in Muhimbili Medical Centre, Dar es Salaam, Tanzania.
Matee MI; Lyamuya EF; Mbena EC; Magessa PM; Sufi J; Marwa GJ; Mwasulama OJ; Mbwana J
East Afr Med J; 1999 Mar; 76(3):167-71. PubMed ID: 10442119
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of selected viral infections among blood donors deferred for potential risk to blood safety.
Zou S; Fujii K; Johnson S; Spencer B; Washington N; Iv EN; Musavi F; Newman B; Cable R; Rios J; Hillyer KL; Hillyer CD; Dodd RY;
Transfusion; 2006 Nov; 46(11):1997-2003. PubMed ID: 17076856
[TBL] [Abstract][Full Text] [Related]
4. Two decades of risk factors and transfusion-transmissible infections in Dutch blood donors.
Slot E; Janssen MP; Marijt-van der Kreek T; Zaaijer HL; van de Laar TJ
Transfusion; 2016 Jan; 56(1):203-14. PubMed ID: 26355711
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of selected viral infections among temporarily deferred donors who returned to donate blood: American Red Cross blood donor study.
Zou S; Musavi F; Notari EP; Fujii KE; Dodd RY;
Transfusion; 2005 Oct; 45(10):1593-600. PubMed ID: 16181210
[TBL] [Abstract][Full Text] [Related]
6. Comparison of prevalence rates of microbiological markers between bone/tissue donations and new blood donors in Scotland.
Galea G; Dow BC
Vox Sang; 2006 Jul; 91(1):28-33. PubMed ID: 16756598
[TBL] [Abstract][Full Text] [Related]
7. Current value of serologic test for syphilis as a surrogate marker for blood-borne viral infections among blood donors in the United States.
Zou S; Notari EP; Fang CT; Stramer SL; Dodd RY
Transfusion; 2009 Apr; 49(4):655-61. PubMed ID: 19170999
[TBL] [Abstract][Full Text] [Related]
8. Reducing the risk of transfusion-transmissible viral infection through blood donor selection: the Australian experience 2000 through 2006.
Polizzotto MN; Wood EM; Ingham H; Keller AJ;
Transfusion; 2008 Jan; 48(1):55-63. PubMed ID: 17894794
[TBL] [Abstract][Full Text] [Related]
9. Limited effectiveness of donor deferral registries for transfusion-transmitted disease markers.
Cable R; Musavi F; Notari E; Zou S;
Transfusion; 2008 Jan; 48(1):34-42. PubMed ID: 17894796
[TBL] [Abstract][Full Text] [Related]
10. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
[TBL] [Abstract][Full Text] [Related]
11. Diversity and origin of hepatitis C virus infection among unpaid blood donors in the Netherlands.
van de Laar TJ; Koppelman MH; van der Bij AK; Zaaijer HL; Cuijpers HT; van der Poel CL; Coutinho RA; Bruisten SM
Transfusion; 2006 Oct; 46(10):1719-28. PubMed ID: 17002628
[TBL] [Abstract][Full Text] [Related]
12. A study on the epidemiology of hepatitis C infection among blood donors in Singapore.
Wang JE
J Public Health Med; 1995 Dec; 17(4):387-91. PubMed ID: 8639336
[TBL] [Abstract][Full Text] [Related]
13. Lessons and opportunities from epidemiologic and molecular investigations of infected blood donors.
Busch MP
Transfusion; 2006 Oct; 46(10):1663-6. PubMed ID: 17002621
[No Abstract] [Full Text] [Related]
14. Donor testing and risk: current prevalence, incidence, and residual risk of transfusion-transmissible agents in US allogeneic donations.
Zou S; Stramer SL; Dodd RY
Transfus Med Rev; 2012 Apr; 26(2):119-28. PubMed ID: 21871776
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for human immunodeficiency virus infection among blood donors in Sao Paulo, Brazil, and their relevance to current donor deferral criteria.
de Almeida Neto C; McFarland W; Murphy EL; Chen S; Nogueira FA; Mendrone A; Salles NA; Chamone DA; Sabino EC
Transfusion; 2007 Apr; 47(4):608-14. PubMed ID: 17381618
[TBL] [Abstract][Full Text] [Related]
16. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study.
Schreiber GB; Busch MP; Kleinman SH; Korelitz JJ
N Engl J Med; 1996 Jun; 334(26):1685-90. PubMed ID: 8637512
[TBL] [Abstract][Full Text] [Related]
17. Profile of transfusion transmissible infections and associated risk factors among blood donors of Kerala.
Mathai J; Sulochana PV; Satyabhama S; Nair PK; Sivakumar S
Indian J Pathol Microbiol; 2002 Jul; 45(3):319-22. PubMed ID: 12785175
[TBL] [Abstract][Full Text] [Related]
18. [Seroprevalence of markers of transfusion transmissible infections in blood bank in Colombia].
Bedoya JA; Cortés Márquez MM; Cardona Arias JA
Rev Saude Publica; 2012 Dec; 46(6):950-9. PubMed ID: 23503536
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis infections among blood donors at the Muhimbili National Hospital in Dar es Salaam, Tanzania.
Matee MI; Magesa PM; Lyamuya EF
BMC Public Health; 2006 Jan; 6():21. PubMed ID: 16445860
[TBL] [Abstract][Full Text] [Related]
20. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
